z-logo
open-access-imgOpen Access
ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
Author(s) -
Maria Kalyuga,
David GallegoOrtega,
Heather Lee,
Daniel Roden,
Mark J. Cowley,
C. Elizabeth Caldon,
Andrew Stone,
Stephanie L. Allerdice,
Fátima ValdésMora,
Rosalind Launchbury,
Aaron L. Statham,
Nicola J. Armstrong,
M. Chehani Alles,
Adelaide I.J. Young,
Andrea Egger,
Wendy W.Y. Au,
Catherine Piggin,
Cara J. Evans,
Anita Ledger,
Tilman Brummer,
Samantha R. Oakes,
Warren Kaplan,
Julia M.W. Gee,
Robert I. Nicholson,
Robert L. Sutherland,
Alexander Swarbrick,
Matthew J. Naylor,
Susan J. Clark,
Jason S. Carroll,
Christopher J. Ormandy
Publication year - 2012
Publication title -
plos biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.127
H-Index - 271
eISSN - 1545-7885
pISSN - 1544-9173
DOI - 10.1371/journal.pbio.1001461
Subject(s) - biology , breast cancer , tamoxifen , estrogen receptor , antiestrogen , foxa1 , cancer research , estrogen , gene knockdown , medicine , chromatin immunoprecipitation , estrogen receptor alpha , cancer , endocrinology , gene expression , genetics , gene , promoter
The transcription factor ELF5 is responsible for gene expression patterning underlying molecular subtypes of breast cancer and may mediate acquired resistance to anti-estrogen therapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom